Brigham and Women & #39;s Hospital to Lead Phase III Clinical Trial for New Class of Medication for Patients with Atherosclerosis

Brigham and Women's Hospital announced today that it will lead a large-scale global phase III clinical trial for a new class of anti-platelet heart medication for patients who have had a heart attack, stroke or existing peripheral arterial disease.
Source: BWH News - Category: Hospital Management Source Type: news